WO1993021874A3 - Subconjunctival implants for ocular drug delivery - Google Patents
Subconjunctival implants for ocular drug delivery Download PDFInfo
- Publication number
- WO1993021874A3 WO1993021874A3 PCT/US1993/003776 US9303776W WO9321874A3 WO 1993021874 A3 WO1993021874 A3 WO 1993021874A3 US 9303776 W US9303776 W US 9303776W WO 9321874 A3 WO9321874 A3 WO 9321874A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- eye
- conjunctiva
- active agent
- drug delivery
- under
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/878,034 | 1992-05-04 | ||
US07/878,034 US5178635A (en) | 1992-05-04 | 1992-05-04 | Method for determining amount of medication in an implantable device |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1993021874A2 WO1993021874A2 (en) | 1993-11-11 |
WO1993021874A3 true WO1993021874A3 (en) | 1994-01-06 |
Family
ID=25371235
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1993/003776 WO1993021874A2 (en) | 1992-05-04 | 1993-04-22 | Subconjunctival implants for ocular drug delivery |
Country Status (3)
Country | Link |
---|---|
US (3) | US5178635A (en) |
AU (1) | AU4111093A (en) |
WO (1) | WO1993021874A2 (en) |
Families Citing this family (249)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6197056B1 (en) * | 1992-07-15 | 2001-03-06 | Ras Holding Corp. | Segmented scleral band for treatment of presbyopia and other eye disorders |
US6966927B1 (en) | 1992-08-07 | 2005-11-22 | Addition Technology, Inc. | Hybrid intrastromal corneal ring |
IL106587A (en) * | 1992-08-07 | 1998-03-10 | Keravision Inc | Hybrid intrastromal corneal ring |
US5304118A (en) * | 1992-12-16 | 1994-04-19 | Trese Michael T | Method for performing a vitrectomy on an eye |
CA2168347A1 (en) | 1993-08-02 | 1995-02-09 | Thomas A. Silvestrini | Segmented preformed intrastromal corneal insert |
US5443505A (en) * | 1993-11-15 | 1995-08-22 | Oculex Pharmaceuticals, Inc. | Biocompatible ocular implants |
US5869079A (en) * | 1995-06-02 | 1999-02-09 | Oculex Pharmaceuticals, Inc. | Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
US5773019A (en) * | 1995-09-27 | 1998-06-30 | The University Of Kentucky Research Foundation | Implantable controlled release device to deliver drugs directly to an internal portion of the body |
US5743274A (en) * | 1996-03-18 | 1998-04-28 | Peyman; Gholam A. | Macular bandage for use in the treatment of subretinal neovascular members |
US7655002B2 (en) | 1996-03-21 | 2010-02-02 | Second Sight Laser Technologies, Inc. | Lenticular refractive surgery of presbyopia, other refractive errors, and cataract retardation |
US6299895B1 (en) | 1997-03-24 | 2001-10-09 | Neurotech S.A. | Device and method for treating ophthalmic diseases |
US5904144A (en) * | 1996-03-22 | 1999-05-18 | Cytotherapeutics, Inc. | Method for treating ophthalmic diseases |
US6024719A (en) | 1998-07-06 | 2000-02-15 | Morris; Robert E | Method and apparatus for performing surgery inside the human retina using fluidic internal limiting membrane (ILM) seperation (FILMS) |
EP1154691A4 (en) * | 1999-01-05 | 2004-07-07 | Massachusetts Eye & Ear Infirm | Targeted transscleral controlled release drug delivery to the retina and choroid |
US6217895B1 (en) * | 1999-03-22 | 2001-04-17 | Control Delivery Systems | Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
US20030070676A1 (en) * | 1999-08-05 | 2003-04-17 | Cooper Joel D. | Conduits having distal cage structure for maintaining collateral channels in tissue and related methods |
US20040073155A1 (en) * | 2000-01-14 | 2004-04-15 | Broncus Technologies, Inc. | Methods and devices for maintaining patency of surgically created channels in tissue |
ATE258768T1 (en) * | 1999-08-05 | 2004-02-15 | Broncus Tech Inc | METHOD AND DEVICES FOR PRODUCING COLLATERAL CHANNELS IN THE LUNGS |
US7462162B2 (en) | 2001-09-04 | 2008-12-09 | Broncus Technologies, Inc. | Antiproliferative devices for maintaining patency of surgically created channels in a body organ |
US20030130657A1 (en) * | 1999-08-05 | 2003-07-10 | Tom Curtis P. | Devices for applying energy to tissue |
US20050060044A1 (en) * | 1999-08-05 | 2005-03-17 | Ed Roschak | Methods and devices for maintaining patency of surgically created channels in a body organ |
US20050137715A1 (en) * | 1999-08-05 | 2005-06-23 | Broncus Technologies, Inc. | Methods and devices for maintaining patency of surgically created channels in a body organ |
CN1292721C (en) * | 1999-10-21 | 2007-01-03 | 爱尔康公司 | Drug delivery device |
PT1221918E (en) | 1999-10-21 | 2005-06-30 | Alcon Inc | ADMINISTRATION OF SUB-TENON DRUGS |
US6416777B1 (en) | 1999-10-21 | 2002-07-09 | Alcon Universal Ltd. | Ophthalmic drug delivery device |
US7943162B2 (en) * | 1999-10-21 | 2011-05-17 | Alcon, Inc. | Drug delivery device |
US6331313B1 (en) | 1999-10-22 | 2001-12-18 | Oculex Pharmaceticals, Inc. | Controlled-release biocompatible ocular drug delivery implant devices and methods |
US6375972B1 (en) | 2000-04-26 | 2002-04-23 | Control Delivery Systems, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
US6726918B1 (en) | 2000-07-05 | 2004-04-27 | Oculex Pharmaceuticals, Inc. | Methods for treating inflammation-mediated conditions of the eye |
ES2312456T3 (en) * | 2000-08-30 | 2009-03-01 | Johns Hopkins University | DEVICES FOR INTRAOCULAR SUPPLY OF PHARMACOS. |
US20060177416A1 (en) | 2003-10-14 | 2006-08-10 | Medivas, Llc | Polymer particle delivery compositions and methods of use |
DE60114229T2 (en) | 2000-11-29 | 2006-07-06 | Allergan, Inc., Irvine | PREVENTING TRANSPLANT DISCHARGE IN THE EYE |
US6697668B2 (en) * | 2001-01-25 | 2004-02-24 | Iomed, Inc. | Ocular iontophoretic device and method for using the same |
US6546284B2 (en) * | 2001-01-25 | 2003-04-08 | Iomed, Inc. | Fluid retention assembly for an iontophoretic delivery device and associated method for preparing the same |
ES2295344T3 (en) * | 2001-04-27 | 2008-04-16 | Eyesense Ag | KIT FOR MEASURING GLUCOSE CONCENTRATIONS IN BLOOD. |
WO2002089767A1 (en) | 2001-05-03 | 2002-11-14 | Massachusetts Eye And Ear Infirmary | Implantable drug delivery device and use thereof |
US6982090B2 (en) * | 2001-05-10 | 2006-01-03 | Gillespie Donald E | More easily visualized punctum plug configurations |
EP2316394B1 (en) | 2001-06-12 | 2016-11-23 | The Johns Hopkins University | Reservoir device for intraocular drug delivery |
WO2003009784A1 (en) * | 2001-07-23 | 2003-02-06 | Alcon, Inc. | Ophthalmic drug delivery device |
CN1203814C (en) | 2001-07-23 | 2005-06-01 | 爱尔康公司 | Opthalmic drug delivery device |
US7708712B2 (en) | 2001-09-04 | 2010-05-04 | Broncus Technologies, Inc. | Methods and devices for maintaining patency of surgically created channels in a body organ |
US20060280772A1 (en) * | 2001-09-04 | 2006-12-14 | Broncus Technologies, Inc. | Methods and devices for maintaining surgically created channels in a body organ |
US20050137611A1 (en) * | 2001-09-04 | 2005-06-23 | Broncus Technologies, Inc. | Methods and devices for maintaining surgically created channels in a body organ |
US20050060042A1 (en) * | 2001-09-04 | 2005-03-17 | Broncus Technologies, Inc. | Methods and devices for maintaining surgically created channels in a body organ |
US7776026B2 (en) * | 2002-02-06 | 2010-08-17 | Nuvue Technologies, Inc. | Method for vitreous liquefaction |
US20110306997A9 (en) * | 2002-02-21 | 2011-12-15 | Roschak Edmund J | Devices for creating passages and sensing for blood vessels |
SI1484054T1 (en) * | 2002-02-22 | 2012-12-31 | Santen Pharmaceutical Co. Ltd. | Drug delivery system for the subconjunctival administration of fine grains |
AU2003218127B2 (en) * | 2002-03-11 | 2007-07-12 | Alcon, Inc. | Implantable drug delivery system |
WO2003088820A2 (en) * | 2002-04-19 | 2003-10-30 | Broncus Technologies, Inc. | Devices for maintaining surgically created openings |
WO2003092665A2 (en) * | 2002-05-02 | 2003-11-13 | Massachusetts Eye And Ear Infirmary | Ocular drug delivery systems and use thereof |
US8871241B2 (en) | 2002-05-07 | 2014-10-28 | Psivida Us, Inc. | Injectable sustained release delivery devices |
US7678827B2 (en) * | 2002-07-15 | 2010-03-16 | Alcon, Inc. | Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use |
US20070184089A1 (en) * | 2002-07-15 | 2007-08-09 | Alcon, Inc. | Non-Polymeric Lipophilic Pharmaceutical Implant Compositions for Intraocular Use |
US6899717B2 (en) * | 2002-09-18 | 2005-05-31 | Allergan, Inc. | Methods and apparatus for delivery of ocular implants |
TWI282271B (en) * | 2002-09-18 | 2007-06-11 | Allergan Inc | Apparatus for delivery of ocular implants |
US7468065B2 (en) | 2002-09-18 | 2008-12-23 | Allergan, Inc. | Apparatus for delivery of ocular implants |
CA2510850A1 (en) * | 2002-12-19 | 2004-07-08 | Pfizer Inc. | 2-(1h-indazol-6-ylamino)-benzamide compounds as protein kinases inhibitors useful for the treatment of ophthalmic diseases |
US20050048099A1 (en) | 2003-01-09 | 2005-03-03 | Allergan, Inc. | Ocular implant made by a double extrusion process |
WO2004073551A2 (en) * | 2003-02-18 | 2004-09-02 | Massachusetts Eye And Ear Infirmary | Transscleral drug delivery device and related methods |
DE602004028638D1 (en) * | 2003-05-02 | 2010-09-23 | Surmodics Inc | System for the controlled release of a bioactive agent in the back of the eye |
US8246974B2 (en) * | 2003-05-02 | 2012-08-21 | Surmodics, Inc. | Medical devices and methods for producing the same |
FR2855761B1 (en) * | 2003-06-03 | 2006-02-24 | Optis France Sa | OCULAR DEVICE FOR VARIABLE DELIVERY OF ACTIVE PRINCIPLES BY IONTOPHORESIS |
CA2522592A1 (en) * | 2003-07-10 | 2005-02-03 | Alcon, Inc. | Ophthalmic drug delivery device |
US20050009910A1 (en) * | 2003-07-10 | 2005-01-13 | Allergan, Inc. | Delivery of an active drug to the posterior part of the eye via subconjunctival or periocular delivery of a prodrug |
US8308682B2 (en) | 2003-07-18 | 2012-11-13 | Broncus Medical Inc. | Devices for maintaining patency of surgically created channels in tissue |
CN1835735B (en) * | 2003-08-20 | 2010-05-12 | 参天制药株式会社 | Drug delivery system for administering fine particle under tenon's capsule |
US7585517B2 (en) * | 2003-09-18 | 2009-09-08 | Macusight, Inc. | Transscleral delivery |
US20070160622A1 (en) * | 2005-12-07 | 2007-07-12 | Medivas, Llc | Method for assembling a polymer-biologic delivery composition |
US20070224278A1 (en) | 2003-11-12 | 2007-09-27 | Lyons Robert T | Low immunogenicity corticosteroid compositions |
WO2005048873A2 (en) * | 2003-11-12 | 2005-06-02 | Alcon, Inc. | Kit for administration of a drug |
US20050101582A1 (en) | 2003-11-12 | 2005-05-12 | Allergan, Inc. | Compositions and methods for treating a posterior segment of an eye |
US20050250737A1 (en) * | 2003-11-12 | 2005-11-10 | Allergan, Inc. | Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods |
US20060141049A1 (en) * | 2003-11-12 | 2006-06-29 | Allergan, Inc. | Triamcinolone compositions for intravitreal administration to treat ocular conditions |
ES2318453T3 (en) | 2004-01-20 | 2009-05-01 | Allergan, Inc. | COMPOSITIONS FOR LOCALIZED EYE THERAPY, WHICH INCLUDE, PREFERENCE, ACETONID TRIAMCINOLONE AND HIALURONIC ACID. |
US7276050B2 (en) | 2004-03-02 | 2007-10-02 | Alan Franklin | Trans-scleral drug delivery method and apparatus |
US20050232972A1 (en) | 2004-04-15 | 2005-10-20 | Steven Odrich | Drug delivery via punctal plug |
US9498457B2 (en) | 2004-04-30 | 2016-11-22 | Allergan, Inc. | Hypotensive prostamide-containing biodegradable intraocular implants and related implants |
US7993634B2 (en) | 2004-04-30 | 2011-08-09 | Allergan, Inc. | Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods |
US8722097B2 (en) | 2004-04-30 | 2014-05-13 | Allergan, Inc. | Oil-in-water method for making polymeric implants containing a hypotensive lipid |
US20050244463A1 (en) | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Sustained release intraocular implants and methods for treating ocular vasculopathies |
US8673341B2 (en) * | 2004-04-30 | 2014-03-18 | Allergan, Inc. | Intraocular pressure reduction with intracameral bimatoprost implants |
US8455656B2 (en) | 2004-04-30 | 2013-06-04 | Allergan, Inc. | Kinase inhibitors |
US20050244458A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Sustained release intraocular implants and methods for treating ocular neuropathies |
US20070059336A1 (en) * | 2004-04-30 | 2007-03-15 | Allergan, Inc. | Anti-angiogenic sustained release intraocular implants and related methods |
US20050244472A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Intraocular drug delivery systems containing excipients with reduced toxicity and related methods |
US8591885B2 (en) * | 2004-04-30 | 2013-11-26 | Allergan, Inc. | Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems |
US7771742B2 (en) | 2004-04-30 | 2010-08-10 | Allergan, Inc. | Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods |
US8425929B2 (en) | 2004-04-30 | 2013-04-23 | Allergan, Inc. | Sustained release intraocular implants and methods for preventing retinal dysfunction |
US20050244461A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Controlled release drug delivery systems and methods for treatment of an eye |
US20050244465A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Drug delivery systems and methods for treatment of an eye |
US20050244469A1 (en) | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Extended therapeutic effect ocular implant treatments |
BRPI0510485A (en) | 2004-04-30 | 2007-11-13 | Allergan Inc | biodegradable intravitreal tyrosine kinase inhibitor implants |
US20050244466A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Photodynamic therapy in conjunction with intraocular implants |
US20050244462A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Devices and methods for treating a mammalian eye |
US8147865B2 (en) | 2004-04-30 | 2012-04-03 | Allergan, Inc. | Steroid-containing sustained release intraocular implants and related methods |
US20050244471A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Estradiol derivative and estratopone containing sustained release intraocular implants and related methods |
US7799336B2 (en) | 2004-04-30 | 2010-09-21 | Allergan, Inc. | Hypotensive lipid-containing biodegradable intraocular implants and related methods |
US8119154B2 (en) | 2004-04-30 | 2012-02-21 | Allergan, Inc. | Sustained release intraocular implants and related methods |
US20050244478A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Anti-excititoxic sustained release intraocular implants and related methods |
US20060024350A1 (en) * | 2004-06-24 | 2006-02-02 | Varner Signe E | Biodegradable ocular devices, methods and systems |
WO2006014484A2 (en) * | 2004-07-02 | 2006-02-09 | Surmodics, Inc. | Methods and devices for the treatment of ocular conditions |
EP2377569A1 (en) | 2004-07-02 | 2011-10-19 | QLT Plug Delivery, Inc. | Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such a delivery device |
BRPI0513243B8 (en) * | 2004-07-12 | 2021-05-25 | Allergan Inc | ophthalmic compositions and their uses |
CA2591543A1 (en) * | 2004-07-19 | 2006-02-09 | Broncus Technologies, Inc. | Methods and devices for maintaining patency of surgically created channels in a body organ |
US8409167B2 (en) * | 2004-07-19 | 2013-04-02 | Broncus Medical Inc | Devices for delivering substances through an extra-anatomic opening created in an airway |
WO2006023130A2 (en) * | 2004-08-12 | 2006-03-02 | Surmodics, Inc. | Biodegradable controlled release bioactive agent delivery device |
US20060047250A1 (en) * | 2004-08-30 | 2006-03-02 | Hickingbotham Dyson W | Fluid delivery device |
US7226435B2 (en) * | 2004-10-14 | 2007-06-05 | Alcon, Inc. | Drug delivery device |
US20060107555A1 (en) * | 2004-11-09 | 2006-05-25 | Curtis Marc D | Universal snow plow adapter |
EP1819325A2 (en) * | 2004-12-22 | 2007-08-22 | Alcon, Inc. | Device for ophthalmic drug delivery |
DK1848431T3 (en) * | 2005-02-09 | 2016-04-18 | Santen Pharmaceutical Co Ltd | LIQUID FORMULATIONS FOR TREATMENT OF DISEASES OR CONDITIONS |
US8663639B2 (en) * | 2005-02-09 | 2014-03-04 | Santen Pharmaceutical Co., Ltd. | Formulations for treating ocular diseases and conditions |
US20060204548A1 (en) | 2005-03-01 | 2006-09-14 | Allergan, Inc. | Microimplants for ocular administration |
BRPI0615962A2 (en) | 2005-07-27 | 2011-05-31 | Univ Florida | use of a compound selected from the group consisting of a proteasome inhibitor, an autophagy inhibitor, a lysosomal inhibitor, an golgi er protein transport inhibitor, an hsp90 chaperonin inhibitor, a heat shock response activator, a and a histone deacetylase inhibitor, use of 11-cis-retinal or 9-cis-retinal and a compound selected from the group consisting of a proteasome inhibitor, an autophagy inhibitor, a lissosomal inhibitor, a er to golgi protein, a hsp90 chaperonin inhibitor, a heat shock response activator, a glycosidase inhibitor, and a histone deacetylase inhibitor, a method for increasing the amount of a biochemically functional conformation of a protein in a cell, composition pharmaceutical for the treatment of an ocular pcd, pharmaceutical composition for the treatment of retinitis pigmentosa, kit for the treatment of an ocular pcd, kit for the treatment retinitis pigmentosa, method for identifying a compound useful for the treatment of an individual having an ocular pcd, method for identifying a compound useful for the treatment of an individual having retinitis pigmentosa, use of a proteasome inhibitor or a autophagy inhibitor and method for producing a recombinant protein in a biochemically functional conformation |
US20070060887A1 (en) * | 2005-08-22 | 2007-03-15 | Marsh David A | Ophthalmic injector |
US20070212397A1 (en) * | 2005-09-15 | 2007-09-13 | Roth Daniel B | Pharmaceutical delivery device and method for providing ocular treatment |
WO2007038246A2 (en) * | 2005-09-22 | 2007-04-05 | Medivas, Llc | Solid polymer delivery compositions and methods for use thereof |
WO2007035938A2 (en) | 2005-09-22 | 2007-03-29 | Medivas, Llc | BIS-(α-AMINO)-DIOL-DIESTER-CONTAINING POLY(ESTER AMIDE) AND POLY(ESTER URETHANE) COMPOSITIONS AND METHODS OF USE |
WO2007047744A2 (en) * | 2005-10-14 | 2007-04-26 | Alcon, Inc. | Method for treating primary and secondary forms of glaucoma |
US20080125406A1 (en) * | 2005-10-14 | 2008-05-29 | Robin Alan L | Method for Treating Primary and Secondary Forms of Glaucoma |
AU2005338015C1 (en) * | 2005-10-31 | 2010-11-18 | Life Spring Biotech Co., Ltd. | Scleral buckle band and method for making it |
EA016227B1 (en) | 2005-11-29 | 2012-03-30 | Смитклайн Бичем Корпорейшн | Method of treating ocular neovascular disorders |
US10842675B2 (en) * | 2006-01-20 | 2020-11-24 | Lensar, Inc. | System and method for treating the structure of the human lens with a laser |
US9545338B2 (en) * | 2006-01-20 | 2017-01-17 | Lensar, Llc. | System and method for improving the accommodative amplitude and increasing the refractive power of the human lens with a laser |
US9889043B2 (en) * | 2006-01-20 | 2018-02-13 | Lensar, Inc. | System and apparatus for delivering a laser beam to the lens of an eye |
US8262646B2 (en) | 2006-01-20 | 2012-09-11 | Lensar, Inc. | System and method for providing the shaped structural weakening of the human lens with a laser |
JP5528708B2 (en) | 2006-02-09 | 2014-06-25 | 参天製薬株式会社 | Stable formulations and methods for preparing and using them |
CN101443004B (en) | 2006-03-23 | 2013-03-06 | 参天制药株式会社 | Formulations and methods for vascular permeability-related diseases or conditions |
CN103393483B (en) | 2006-03-31 | 2016-08-24 | 玛提治疗有限公司 | Medicine release method, structure and composition for nose tear system |
JP5445130B2 (en) * | 2006-05-02 | 2014-03-19 | メディバス エルエルシー | Delivery of ophthalmic drugs to the exterior or interior of the eye |
WO2007133616A2 (en) * | 2006-05-09 | 2007-11-22 | Medivas, Llc | Biodegradable water soluble polymers |
US20070268340A1 (en) * | 2006-05-17 | 2007-11-22 | Bruno Dacquay | Ophthalmic Injection System and Method Using Piezoelectric Array |
US7887521B2 (en) * | 2006-05-17 | 2011-02-15 | Alcon Research, Ltd. | Ophthalmic injection system |
US7871399B2 (en) * | 2006-05-17 | 2011-01-18 | Alcon Research, Ltd. | Disposable ophthalmic injection device |
US7862540B2 (en) * | 2006-05-17 | 2011-01-04 | Alcon Research, Ltd. | Ophthalmic injection device using shape memory alloy |
US20070270750A1 (en) * | 2006-05-17 | 2007-11-22 | Alcon, Inc. | Drug delivery device |
US20070270768A1 (en) * | 2006-05-17 | 2007-11-22 | Bruno Dacquay | Mechanical Linkage Mechanism For Ophthalmic Injection Device |
US7674243B2 (en) * | 2006-05-17 | 2010-03-09 | Alcon Inc. | Ophthalmic injection device using piezoelectric array |
US7811252B2 (en) * | 2006-05-17 | 2010-10-12 | Alcon Research, Ltd. | Dosage control device |
US8668676B2 (en) * | 2006-06-19 | 2014-03-11 | Allergan, Inc. | Apparatus and methods for implanting particulate ocular implants |
CN101563363B (en) | 2006-06-21 | 2013-01-02 | 南卡罗来纳医疗大学研究发展基金会 | Targeting complement factor H for treatment of diseases |
US8802128B2 (en) * | 2006-06-23 | 2014-08-12 | Allergan, Inc. | Steroid-containing sustained release intraocular implants and related methods |
US8911496B2 (en) | 2006-07-11 | 2014-12-16 | Refocus Group, Inc. | Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods |
AU2007272963B2 (en) | 2006-07-11 | 2013-05-23 | Refocus Group, Inc. | Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods |
US20080097335A1 (en) | 2006-08-04 | 2008-04-24 | Allergan, Inc. | Ocular implant delivery assemblies |
US20080097379A1 (en) * | 2006-09-26 | 2008-04-24 | Alcon Manufacturing, Ltd. | Ophthalmic injection method |
US20080125712A1 (en) * | 2006-09-26 | 2008-05-29 | Alcon Manufacturing, Ltd. | Ophthalmic injection system |
US20080097390A1 (en) * | 2006-09-27 | 2008-04-24 | Alcon Manufacturing, Ltd. | Spring actuated delivery system |
US9022970B2 (en) * | 2006-10-16 | 2015-05-05 | Alcon Research, Ltd. | Ophthalmic injection device including dosage control device |
US20080281292A1 (en) * | 2006-10-16 | 2008-11-13 | Hickingbotham Dyson W | Retractable Injection Port |
JP2010510029A (en) * | 2006-11-22 | 2010-04-02 | ブロンカス テクノロジーズ, インコーポレイテッド | Device for passage creation and blood vessel sensing |
US8969415B2 (en) | 2006-12-01 | 2015-03-03 | Allergan, Inc. | Intraocular drug delivery systems |
WO2008073576A1 (en) * | 2006-12-08 | 2008-06-19 | Alcon, Inc. | Drug delivery device |
JP5323720B2 (en) * | 2006-12-18 | 2013-10-23 | アルコン リサーチ, リミテッド | Devices and methods for ophthalmic drug delivery |
US20080243095A1 (en) * | 2007-03-26 | 2008-10-02 | Theta Research Consultants, Llc | Method and Apparatus for Ophthalmic Medication Delivery and Ocular Wound Recovery |
WO2008124940A1 (en) | 2007-04-12 | 2008-10-23 | Waratah Pharmaceuticals Inc. | Use of cyclohexanehexol derivatives in the treatment of ocular diseases |
US7911053B2 (en) * | 2007-04-19 | 2011-03-22 | Marvell World Trade Ltd. | Semiconductor packaging with internal wiring bus |
US20080265343A1 (en) * | 2007-04-26 | 2008-10-30 | International Business Machines Corporation | Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof |
DE102007024642A1 (en) | 2007-05-24 | 2008-11-27 | Eyesense Ag | Hydrogel implant for sensor of metabolites on the eye |
US20090018548A1 (en) * | 2007-07-13 | 2009-01-15 | Charles Steven T | Pneumatically-Powered Intraocular Lens Injection Device with Removable Cartridge |
US20090018512A1 (en) * | 2007-07-13 | 2009-01-15 | Charles Steven T | Pneumatically-Powered Ophthalmic Injector |
CA2709412A1 (en) * | 2007-07-24 | 2009-01-29 | Medivas, Llc | Biodegradable cationic polymer gene transfer compositions and methods of use |
US7740619B2 (en) * | 2007-08-01 | 2010-06-22 | Alcon Research, Ltd. | Spring driven ophthalmic injection device with safety actuator lockout feature |
JP5323073B2 (en) * | 2007-08-02 | 2013-10-23 | リフォーカス グループ、インコーポレイテッド | Scleral prosthesis with a crossbar for treating presbyopia and other eye diseases |
US20090036842A1 (en) * | 2007-08-03 | 2009-02-05 | Raffi Pinedjian | Consumable Activation Lever For Injection Device |
US7629768B2 (en) * | 2007-08-03 | 2009-12-08 | Alcon Research, Ltd. | Easy cleaning C-shaped charging base |
EP3372205A1 (en) * | 2007-09-07 | 2018-09-12 | Mati Therapeutics Inc. | Lacrimal implant detection |
TWI451862B (en) * | 2007-10-09 | 2014-09-11 | Alcon Res Ltd | Thermal coefficient driven drug pellet size for ophthalmic injection |
TWI498136B (en) * | 2007-10-09 | 2015-09-01 | Alcon Res Ltd | An injection device for delivering a rate and temperature-dependent substance into the eye and method of preparing the same |
WO2009061988A1 (en) | 2007-11-08 | 2009-05-14 | Alimera Sciences, Inc. | Ocular implantation device |
US20100152646A1 (en) * | 2008-02-29 | 2010-06-17 | Reshma Girijavallabhan | Intravitreal injection device and method |
US8267882B2 (en) * | 2008-03-05 | 2012-09-18 | Ivantis, Inc. | Methods and apparatus for treating glaucoma |
US20100022996A1 (en) * | 2008-07-25 | 2010-01-28 | Frey Rudolph W | Method and system for creating a bubble shield for laser lens procedures |
US8480659B2 (en) * | 2008-07-25 | 2013-07-09 | Lensar, Inc. | Method and system for removal and replacement of lens material from the lens of an eye |
US8500723B2 (en) * | 2008-07-25 | 2013-08-06 | Lensar, Inc. | Liquid filled index matching device for ophthalmic laser procedures |
JP2012500207A (en) * | 2008-08-13 | 2012-01-05 | メディバス エルエルシー | AABB-poly (depsipeptide) biodegradable polymer and method of use |
CA2744245A1 (en) * | 2008-11-19 | 2010-05-27 | Refocus Group, Inc. | Artificial intraocular lens, altered natural crystalline lens, or refilled natural crystalline lens capsule with one or more scleral prostheses for improved performance |
US20100158980A1 (en) | 2008-12-18 | 2010-06-24 | Casey Kopczynski | Drug delivery devices for delivery of therapeutic agents |
US8545554B2 (en) | 2009-01-16 | 2013-10-01 | Allergan, Inc. | Intraocular injector |
US8623395B2 (en) | 2010-01-29 | 2014-01-07 | Forsight Vision4, Inc. | Implantable therapeutic device |
WO2010088548A1 (en) | 2009-01-29 | 2010-08-05 | Forsight Labs, Llc | Posterior segment drug delivery |
WO2010101758A1 (en) * | 2009-03-03 | 2010-09-10 | Alcon Research, Ltd. | Peri-corneal drug delivery device |
US8632511B2 (en) * | 2009-05-06 | 2014-01-21 | Alcon Research, Ltd. | Multiple thermal sensors in a multiple processor environment for temperature control in a drug delivery device |
WO2010141729A1 (en) | 2009-06-03 | 2010-12-09 | Forsight Labs, Llc | Anterior segment drug delivery |
IN2012DN00352A (en) | 2009-06-16 | 2015-08-21 | Bikam Pharmaceuticals Inc | |
US8758332B2 (en) * | 2009-07-24 | 2014-06-24 | Lensar, Inc. | Laser system and method for performing and sealing corneal incisions in the eye |
US8617146B2 (en) | 2009-07-24 | 2013-12-31 | Lensar, Inc. | Laser system and method for correction of induced astigmatism |
JP2013500078A (en) * | 2009-07-24 | 2013-01-07 | レンサー, インク. | System and method for irradiating a lens of an eye with a laser irradiation pattern |
US8382745B2 (en) * | 2009-07-24 | 2013-02-26 | Lensar, Inc. | Laser system and method for astigmatic corrections in association with cataract treatment |
CN102639078B (en) * | 2009-07-24 | 2015-10-21 | 能斯雅有限公司 | A kind of is the para-operative system and method for eye lens enforcement laser radar |
CN102625685B (en) * | 2009-07-24 | 2015-11-25 | 能斯雅有限公司 | For the liquid storage interface equipment of ophthalmology laser surgery |
WO2011039648A1 (en) | 2009-09-30 | 2011-04-07 | Glaxo Wellcome Manufacturing Pte Ltd. | Methods of administration and treatment |
CN102724951A (en) | 2009-11-09 | 2012-10-10 | 阿勒根公司 | Compositions and methods for stimulating hair growth |
US8177747B2 (en) * | 2009-12-22 | 2012-05-15 | Alcon Research, Ltd. | Method and apparatus for drug delivery |
WO2013022801A1 (en) | 2011-08-05 | 2013-02-14 | Forsight Vision4, Inc. | Small molecule delivery with implantable therapeutic device |
WO2011094666A1 (en) * | 2010-02-01 | 2011-08-04 | Lensar, Inc. | Placido ring measurement of astigmatism axis and laser marking of astigmatism axis |
EP2531089B1 (en) | 2010-02-01 | 2023-04-05 | LENSAR, Inc. | Purkinjie image-based alignment of suction ring in ophthalmic applications |
CA2798084A1 (en) | 2010-05-17 | 2011-11-24 | Aerie Pharmaceuticals, Inc. | Drug delivery devices for delivery of ocular therapeutic agents |
MX2012014975A (en) | 2010-06-22 | 2013-03-12 | Univ Colorado Regents | Antibodies to the c3d fragment of complement component 3. |
CN105435338B (en) | 2010-08-05 | 2019-03-26 | 弗赛特影像4股份有限公司 | Injector apparatus and method for drug conveying |
WO2012019139A1 (en) | 2010-08-05 | 2012-02-09 | Forsight Vision4, Inc. | Combined drug delivery methods and apparatus |
PL2600812T3 (en) | 2010-08-05 | 2022-01-24 | Forsight Vision4, Inc. | Apparatus to treat an eye |
US8915877B2 (en) | 2010-10-12 | 2014-12-23 | Emmett T. Cunningham, JR. | Glaucoma drainage device and uses thereof |
US9370444B2 (en) | 2010-10-12 | 2016-06-21 | Emmett T. Cunningham, JR. | Subconjunctival conformer device and uses thereof |
USD694890S1 (en) | 2010-10-15 | 2013-12-03 | Lensar, Inc. | Laser system for treatment of the eye |
USD695408S1 (en) | 2010-10-15 | 2013-12-10 | Lensar, Inc. | Laser system for treatment of the eye |
CN103338692B (en) | 2010-10-15 | 2016-12-28 | 雷萨有限责任公司 | The system and method for the scan control illumination of the structure of inside ofeye |
US20140031769A1 (en) | 2010-11-19 | 2014-01-30 | Forsight Vision4, Inc. | Therapeutic agent formulations for implanted devices |
US10463541B2 (en) | 2011-03-25 | 2019-11-05 | Lensar, Inc. | System and method for correcting astigmatism using multiple paired arcuate laser generated corneal incisions |
US8709034B2 (en) | 2011-05-13 | 2014-04-29 | Broncus Medical Inc. | Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall |
WO2012158530A1 (en) | 2011-05-13 | 2012-11-22 | Broncus Technologies, Inc. | Methods and devices for ablation of tissue |
US9133082B2 (en) | 2011-06-14 | 2015-09-15 | Bikam Pharmaceuticals, Inc. | Opsin-binding ligands, compositions and methods of use |
CN103748139B (en) | 2011-06-23 | 2016-08-17 | 帝斯曼知识产权资产管理有限公司 | For delivering the micron particle comprising biodegradable polyester-amide copolymer or the nano-particle of bioactivator |
US9873765B2 (en) | 2011-06-23 | 2018-01-23 | Dsm Ip Assets, B.V. | Biodegradable polyesteramide copolymers for drug delivery |
EP4249059A3 (en) | 2011-06-28 | 2023-11-29 | ForSight Vision4, Inc. | An apparatus for collecting a sample of fluid from a reservoir chamber of a therapeutic device for the eye |
CN106073986B (en) | 2011-09-14 | 2019-01-11 | 弗赛特影像5股份有限公司 | The device for treating the eyes of patient |
SI2755600T1 (en) | 2011-09-16 | 2021-08-31 | Forsight Vision4, Inc. | Fluid exchange apparatus |
US20150010634A1 (en) | 2011-10-12 | 2015-01-08 | Ascendis Pharma Ophthamology Division A/S | Prevention and treatment of ocular conditions |
US9499464B2 (en) | 2011-10-19 | 2016-11-22 | Bikam Pharmaceuticals, Inc. | Opsin-binding ligands, compositions and methods of use |
US9393154B2 (en) | 2011-10-28 | 2016-07-19 | Raymond I Myers | Laser methods for creating an antioxidant sink in the crystalline lens for the maintenance of eye health and physiology and slowing presbyopia development |
WO2013078235A1 (en) | 2011-11-23 | 2013-05-30 | Broncus Medical Inc | Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall |
EP2785346A4 (en) | 2011-11-30 | 2015-04-29 | Bikam Pharmaceuticals Inc | Opsin-binding ligands, compositions and methods of use |
AU2012346537A1 (en) | 2011-12-01 | 2014-07-17 | Bikam Pharmaceuticals, Inc. | Opsin-binding ligands, compositions and methods of use |
US10010448B2 (en) | 2012-02-03 | 2018-07-03 | Forsight Vision4, Inc. | Insertion and removal methods and apparatus for therapeutic devices |
US9827401B2 (en) | 2012-06-01 | 2017-11-28 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
US9308355B2 (en) | 2012-06-01 | 2016-04-12 | Surmodies, Inc. | Apparatus and methods for coating medical devices |
US11090468B2 (en) | 2012-10-25 | 2021-08-17 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
WO2014066775A1 (en) | 2012-10-26 | 2014-05-01 | Forsight Vision5, Inc. | Ophthalmic system for sustained release of drug to eye |
CA2901280A1 (en) | 2013-02-15 | 2014-08-21 | Allergan, Inc. | Sustained drug delivery implant |
SI2968461T1 (en) | 2013-03-13 | 2023-01-31 | Genzyme Corporation | Fusion proteins comprising pdgf and vegf binding portions and methods of using thereof |
EP2968113B8 (en) | 2013-03-14 | 2020-10-28 | Forsight Vision4, Inc. | Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant |
CN105246438B (en) | 2013-03-28 | 2018-01-26 | 弗赛特影像4股份有限公司 | For conveying the ophthalmic implant of therapeutic substance |
ES2740352T3 (en) | 2013-11-14 | 2020-02-05 | Eyed Pharma | Eye device |
CN114057857A (en) | 2014-06-20 | 2022-02-18 | 豪夫迈·罗氏有限公司 | CHAGASIN-based scaffold compositions, methods and uses |
WO2016004251A1 (en) | 2014-07-01 | 2016-01-07 | Cao Ariel | Hermetically sealed implant sensors with vertical stacking architecture |
WO2016004223A1 (en) | 2014-07-01 | 2016-01-07 | Cao Ariel | Methods and devices for implantation of intraocular pressure sensors |
MY182497A (en) | 2014-07-15 | 2021-01-25 | Forsight Vision4 Inc | Ocular implant delivery device and method |
BR112017002466A2 (en) | 2014-08-08 | 2017-12-05 | Forsight Vision4 Inc | stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods for their preparation |
SG11201703726XA (en) | 2014-11-10 | 2017-06-29 | Forsight Vision4 Inc | Expandable drug delivery devices and method of use |
CN107106509B (en) | 2014-12-18 | 2021-11-30 | 帝斯曼知识产权资产管理有限公司 | Drug delivery system for delivering acid sensitive drugs |
WO2016168141A1 (en) | 2015-04-13 | 2016-10-20 | Forsight Vision5, Inc. | Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent |
US10182939B2 (en) | 2015-09-16 | 2019-01-22 | Novartis Ag | Hydraulic injector and methods for intra-ocular lens insertion |
KR20180084104A (en) | 2015-11-20 | 2018-07-24 | 포사이트 비젼4, 인크. | Porous structures for extended release drug delivery devices |
JP7009384B2 (en) | 2016-04-05 | 2022-01-25 | フォーサイト・ビジョン フォー・インコーポレーテッド | Implantable eye drug delivery device |
AU2017311636B2 (en) | 2016-08-19 | 2023-08-10 | Orasis Pharmaceuticals Ltd. | Ophthalmic pharmaceutical compositions and uses relating thereto |
WO2019103906A1 (en) | 2017-11-21 | 2019-05-31 | Forsight Vision4, Inc. | Fluid exchange apparatus for expandable port delivery system and methods of use |
WO2020112816A1 (en) | 2018-11-29 | 2020-06-04 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
US11819590B2 (en) | 2019-05-13 | 2023-11-21 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
CN117580553A (en) | 2021-07-07 | 2024-02-20 | 基因泰克公司 | Rod inserter system and method |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3995635A (en) * | 1971-09-09 | 1976-12-07 | Alza Corporation | Ocular insert |
US4186184A (en) * | 1977-12-27 | 1980-01-29 | Alza Corporation | Selective administration of drug with ocular therapeutic system |
EP0262893A2 (en) * | 1986-10-02 | 1988-04-06 | Sohrab Darougar | Ocular insert |
EP0316838A1 (en) * | 1987-11-18 | 1989-05-24 | FARMA RESA S.r.l. | Tablet for opthalmic use with controlled release of the active substance |
US4863457A (en) * | 1986-11-24 | 1989-09-05 | Lee David A | Drug delivery device |
US5098443A (en) * | 1989-03-23 | 1992-03-24 | University Of Miami | Method of implanting intraocular and intraorbital implantable devices for the controlled release of pharmacological agents |
WO1992014450A1 (en) * | 1991-02-21 | 1992-09-03 | University Of Kentucky Research Foundation | Sustained release drug delivery devices |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3916899A (en) * | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
US3961628A (en) * | 1974-04-10 | 1976-06-08 | Alza Corporation | Ocular drug dispensing system |
US4052505A (en) * | 1975-05-30 | 1977-10-04 | Alza Corporation | Ocular therapeutic system manufactured from copolymer |
US5030230A (en) * | 1986-05-16 | 1991-07-09 | Great Plains Eye Clinic, Ltd. | Corneal implant |
-
1992
- 1992-05-04 US US07/878,034 patent/US5178635A/en not_active Expired - Lifetime
- 1992-08-10 US US07/926,402 patent/US5300114A/en not_active Expired - Lifetime
-
1993
- 1993-04-22 WO PCT/US1993/003776 patent/WO1993021874A2/en active Application Filing
- 1993-04-22 AU AU41110/93A patent/AU4111093A/en not_active Abandoned
- 1993-07-21 US US08/096,624 patent/US5476511A/en not_active Expired - Fee Related
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3995635A (en) * | 1971-09-09 | 1976-12-07 | Alza Corporation | Ocular insert |
US4186184A (en) * | 1977-12-27 | 1980-01-29 | Alza Corporation | Selective administration of drug with ocular therapeutic system |
EP0262893A2 (en) * | 1986-10-02 | 1988-04-06 | Sohrab Darougar | Ocular insert |
US4863457A (en) * | 1986-11-24 | 1989-09-05 | Lee David A | Drug delivery device |
EP0316838A1 (en) * | 1987-11-18 | 1989-05-24 | FARMA RESA S.r.l. | Tablet for opthalmic use with controlled release of the active substance |
US5098443A (en) * | 1989-03-23 | 1992-03-24 | University Of Miami | Method of implanting intraocular and intraorbital implantable devices for the controlled release of pharmacological agents |
WO1992014450A1 (en) * | 1991-02-21 | 1992-09-03 | University Of Kentucky Research Foundation | Sustained release drug delivery devices |
Also Published As
Publication number | Publication date |
---|---|
US5300114A (en) | 1994-04-05 |
AU4111093A (en) | 1993-11-29 |
WO1993021874A2 (en) | 1993-11-11 |
US5476511A (en) | 1995-12-19 |
US5178635A (en) | 1993-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1993021874A3 (en) | Subconjunctival implants for ocular drug delivery | |
PL287200A1 (en) | Method of making a sticking plaster with an estrogen containing active substance incorporated into adhesive layer thereof | |
CA2104699A1 (en) | Sustained release drug delivery devices | |
CA2301685A1 (en) | Sustained release drug delivery devices | |
IE892736L (en) | Controlled release device with an impermeable coating having¹an orifice for release of drug | |
CA2074467A1 (en) | Skin electrode construction and transdermal drug delivery device utilizing same | |
CA2230947A1 (en) | Implantable controlled release device to deliver drugs directly to an internal portion of the body | |
CA2406277A1 (en) | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof | |
CA2010218A1 (en) | Therapeutic system for the retarded and controlled transdermal or transmucous administration of active substances | |
NZ233152A (en) | Transdermal therapeutic system | |
ATE167622T1 (en) | CLOTHING PROTECTION DEVICE | |
CA2368335A1 (en) | Inflatable device and method for treating glaucoma | |
WO1997004818A3 (en) | Transdermal therapeutic sysgtem for administering active agents to the human body via the skin | |
WO2000010533A3 (en) | Compositions and methods for treating intracellular infections | |
WO1996040074A3 (en) | Device for releasing aggregation-stabilized, biologically active agent | |
WO1994025025A3 (en) | Systems for controlled release of pilocarpine | |
KR920011478A (en) | Ophthalmic Microspheres | |
Kitazawa et al. | Ocular hypotensive effects of carteolol hydrochloride in primary open-angle glaucoma and ocular hypertensive patients. A double-masked cross-over study for the determination of concentrations optimal for the clinical use (author's transl) | |
HRP931391B1 (en) | Transdermal therapeutic system for administering ostigmin through the skin, and a method of producing the system | |
SI8711587A (en) | Transdermal theraupetic system for applaying therapeutical substances throught skin. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AT AU BB BG BR CA CH CZ DE DK ES FI GB HU JP KP KR LK LU MG MN MW NL NO NZ PL PT RO RU SD SE SK UA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AT AU BB BG BR CA CH CZ DE DK ES FI GB HU JP KP KR LK LU MG MN MW NL NO NZ PL PT RO RU SD SE SK UA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |